Bidiphar
Bidiphar is a private pharmaceutical manufacturer founded in 1980, producing pharmaceuticals, oncology drugs, health supplements, and medical equipment. Operating with 101-250 employees, the company serves healthcare markets through diversified therapeutic and medical-device manufacturing.
- Company typePrivate
- Founded1980
- Headquarters—
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bidiphar does
Bidiphar is a private pharmaceutical manufacturer founded in 1980, operating with a workforce in the 101-250 range. According to the available firmographic data, the company manufactures pharmaceuticals, oncology drugs, health supplements, and medical equipment, placing it in the diversified healthcare products segment. The company maintains a web presence at bidiphar.com; however, the live site returned a verification/loading page during data collection rather than substantive content, limiting first-party disclosure.
The firm's product portfolio spans four therapeutic and device categories: human pharmaceuticals, oncology drugs, health supplements, and medical equipment. This breadth indicates a multi-segment business model that likely targets both prescription channels (hospitals, clinics, pharmacies) and consumer health channels (retail supplements). Operating continuously since 1980 gives the company over four decades of operational history, which typically signals established manufacturing capabilities, accumulated product registrations, and distribution relationships within its served markets. The combination of oncology drugs alongside general pharmaceuticals suggests vertically integrated production capabilities spanning both specialized and mass-market therapeutic categories.
Business-model mechanics are not documented in the available input. No revenue figure, customer list, leadership roster, funding history, partnership announcements, regulatory certifications, product catalog, pricing model, or geographic distribution data are present. Source content repeatedly notes that the bidiphar.com page was a verification/loader with no company information, and structured data blocks for ownership, management, partnerships, investments, and contacts are empty. This represents a significant data gap; all analytical outputs below are constrained accordingly.
Bidiphar firmographics
Firmographics- Name
- Bidiphar
- Website
- https://bidiphar.com
- Company type
- Private
- Founded year
- 1980
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Bidiphar is a private pharmaceutical manufacturer founded in 1980, producing pharmaceuticals, oncology drugs, health supplements, and medical equipment. Operating with 101-250 employees, the company serves healthcare markets through diversified therapeutic and medical-device manufacturing.
- Ownership category
- akta.pro rank
Bidiphar industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Oral Solid Dose (OSD) Generics (HLAIABAD)
Keywords
Bidiphar business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D
Bidiphar product offering
Product offeringCore offering
Bidiphar manufactures pharmaceuticals, oncology drugs, health supplements, and medical equipment. The company operates as a for-profit pharmaceutical manufacturer established in 1980, employing 101-250 staff, and produces multiple categories of physical health products for healthcare distribution channels.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceuticals
- Oncology Drugs
- Health Supplements
- Medical Equipment
Companies that use Bidiphar
Customer profileIdeal customer profiles1 record
Bidiphar technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Bidiphar competitors and assessment
Company assessmentDirect peers
- DHG Pharmaceutical (Hau Giang Pharma): One of Vietnam's largest domestic pharmaceutical manufacturers, producing a broad portfolio of generics, OTC, and consumer health products. Highly comparable to Bidiphar as a mid/large-scale Vietnamese finished-dose drug maker.
- Traphaco: Vietnamese pharmaceutical and nutraceutical manufacturer with a strong domestic distribution footprint. Comparable to Bidiphar in combining pharmaceuticals with health supplements and serving the Vietnamese retail and institutional market.
- Imexpharm Pharmaceutical JSC: Vietnamese manufacturer of generic and branded finished-dose pharmaceuticals, including injectables and OSD forms. Closely comparable to Bidiphar in therapeutic breadth, manufacturing scale, and Vietnam-centric distribution.
- Pymepharco: A Franco-Vietnamese pharmaceutical manufacturer producing generics, antibiotics, and finished-dose products for the domestic and export markets. Comparable to Bidiphar on generic finished-dose manufacturing for Vietnam.
- Mekophar Chemical-Pharmaceutical JSC: Vietnamese pharmaceutical and API manufacturer producing finished drugs across multiple therapeutic areas. Comparable to Bidiphar in domestic manufacturing breadth and regulatory profile in Vietnam.
- Hapharco (Hanoi Pharmaceutical & Medical Equipment JSC): Vietnamese pharmaceutical and medical equipment distributor/manufacturer. Directly comparable to Bidiphar's combined pharma and medical equipment offering within Vietnam.
Regional players
- OPC Pharmaceutical JSC: Vietnamese pharmaceutical manufacturer with a focus on generics and traditional/herbal medicines. Comparable to Bidiphar in domestic finished-dose manufacturing with overlap in health supplements.
Broad incumbents
- Sanofi Vietnam: Multinational pharmaceutical company with a strong Vietnamese commercial presence across branded and specialty therapies. Comparable as a competitor in the same Vietnamese pharmaceutical market Bidiphar serves.
- Novartis Vietnam: Global pharmaceutical incumbent operating in Vietnam with branded specialty and oncology portfolios. Comparable to Bidiphar in the Vietnamese oncology/pharma overlap where both compete for institutional buyers.
- Vinapharma (Vietnam Pharmaceutical Corporation): Large state-affiliated Vietnamese pharmaceutical group covering manufacturing, distribution, and retail pharmacy. Comparable to Bidiphar in domestic pharma manufacturing and broad therapeutic coverage.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat3 records
Key risks4 records
Key highlights3 records
Customer concentration
Bidiphar social profiles
Digital presenceBidiphar financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bidiphar leadership team
Management profileNumber of profiles
Bidiphar funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bidiphar M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bidiphar
What does Bidiphar do?
Bidiphar manufactures pharmaceuticals, oncology drugs, health supplements, and medical equipment. The company operates as a for-profit pharmaceutical manufacturer established in 1980, employing 101-250 staff, and produces multiple categories of physical health products for healthcare distribution channels.
Is Bidiphar a public or private company?
Bidiphar is a private company. It is classified as unknown and is currently operating.
When was Bidiphar founded?
Bidiphar was founded in 1980. It employs 101 to 250 people.
Who are Bidiphar's main competitors?
Direct peers on record are DHG Pharmaceutical (Hau Giang Pharma), Traphaco, Imexpharm Pharmaceutical JSC, Pymepharco, Mekophar Chemical-Pharmaceutical JSC and Hapharco (Hanoi Pharmaceutical & Medical Equipment JSC). OPC Pharmaceutical JSC is listed as a regional player. Broad incumbents are Sanofi Vietnam, Novartis Vietnam and Vinapharma (Vietnam Pharmaceutical Corporation).
Does Bidiphar have an API?
No public API is recorded for Bidiphar.
What industry is Bidiphar in?
Bidiphar's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAD, Oral Solid Dose (OSD) Generics. Its NAICS code is 325412 and its SIC code is 2834.